Background: the efficacy and tolerability of the new antidepressant mirtazapine were evaluated in a multicentre, randomized, double-blind, amitriptyline-controlled, 5 week clinical study. Method: 156 patients with a DSM-III diagnosis of major depressive episode and 21-item Hamilton Psychiatric Rating Scale for Depression (HPRSD) score ≥ 18, were randomized to treatment with either mirtazapine 20-60 mg/day or amitriptyline 75-225 mg/day. Results: mirtazapine and amitriptyline were equally effective in reducing depressive symptoms, as assessed by the 17-item HPRSD and MADRS scales. Mirtazapine was better tolerated than amitriptyline, with fewer drop-outs due to adverse events and lower incidences of adverse events both at the beginning and at the end of the trial. Conclusion: this study shows that mirtazapine is as effective as amitriptyline in treating major depression, while at the same time better tolerated.
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, DC
2.
Bremner J.D. (In press) A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. J Clin Psychiatr
3.
Carney M W P, Roth M., Garside R.F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatr111: 659-674
4.
Claghorn J.L., Lessem M. (1995) A double-blind placebo-controlled study of Org 3770 in depressed outpatients. J Affect Dis34:165-171
5.
De Boer Th, Ruigt Gsf (1995) The selective α2-antagonist mirtazapine (Org 3770) enhances noradrenergic and serotonin1Amediated serotonergic neurotransmission. CNS Drugs4 (Suppl 1): 29-38
6.
De Boer T., Nefkens F., van Helvoirt (1994) The α2-adrenoreceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol253: R5-R6
7.
De Boer Th, Ruigt G S F, Berendsen H H G (1995) The α2-selective adrenoreceptor antagonist Org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission. Human Psychopharmacol Suppl2: S107-119
8.
de Montigny C., Haddjeri N., Mongeau R. et al. (1995) The effects of mirtazapine on interactions between central noradrenergic and serotonergic systems. CNS Drugs4 (Suppl 1): 13-17
9.
Endicott J., Spitzer R.I., Fleiss J.I. et al. (1976) The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatr33: 766-771
10.
Goodwin F.K. (1994) Psychiatry. J Am Med Assoc271:1707-1708
11.
Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr23: 56-62
12.
Hamilton M. (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol6: 278-296
13.
Kooyman A.R., Zwart R., Vanderheyden P M L et al. (1994) Interaction between enantiomers of mianserin and Org 3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology33: 501-510
14.
Lehman E.L. (1975) Nonparametrics. McGraw-Hill , New York
15.
Mant A., Duncan-Jones P., Saltman D. et al. (1988) Development of long-term use of psychotropic drugs by general practice patients. Br Med J296: 251-254
16.
Marttila M., Jääskeläinen J., Jarvi R. et al. (In press) A double-blind study comparing the efficacy and tolerability of Org 3770 and doxepin patients with major depression. Eur Neuropsychopharmacol
17.
Montgomery SA, Åsberg M.A. (1979) A new depression rating scale designed to be sensitive to change. Br Psychiatr134: 382-389
18.
Overall J.E., Gorham D. (1961) The Brief Psychiatric Rating Scale (BPRS). Psychol Rep10: 799-812
19.
Richou H., Ruimy P., Charbaut J. et al. (1995) A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3700. Human Psychopharmacol10: 263-271
20.
Ruigt G.S., Kemp B., Groenhout C.M. et al. (1990) Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol38: 551-554
21.
Sitsen J M A, Moors J. (1994) Mirtazapine, a novel antidepressant, in the treatment of anxiety symptoms. Results from a placebo-controlled trial. Drug Invest8: 339-344
22.
Smith W.T., Glaudin V., Panagides J. et al. (1990) Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmacol Bull26: 191-196
23.
Spitzer RL, Endicott J., Robins E. (1978) Research diagnostic criteria: rationale and reliability . Arch Gen Psychiatr53: 773-783
24.
van Moffaert M., de Wilde J., Vereecken A. et al. (1995) Mirtazapine is more effective than trazodone. A controlled study in hospitalised patients with major depression. Int Clin Psychopharmacol10: 3-11
25.
Vestergaard P., Gram L.F., Kragh-Sorensen et al. ( 1993) Therapeutic potentials of recently introduced antidepressants . Psychopharmacol Ser10:190-198
26.
Zivkov M., de Jongh G.D. (1995) Org 3770 vs amitriptyline: a 6-week randomised double-blind multicentre trial in hospitalised patients. Human Psychopharmacol10: 173-180
